David W. J. McGirr
Director · RHYTHM PHARMACEUTICALS, INC.
- 2025
- Jun 25, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David W. J. McGirr files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- William Lewis - $26.07M in INSM purchases and sales in the last 12 months
- Martina M.D. Flammer - $17.99M in INSM purchases and sales in the last 12 months
- Leo Lee - $14.69M in INSM purchases and sales in the last 12 months
- Michael Alexander Smith - $13.45M in INSM purchases and sales in the last 12 months
- Jennifer Kayden Lee - $8.90M in RYTM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David W. J. McGirr?
David W. J. McGirr is a corporate insider, tracked as Director of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David W. J. McGirr last file a Form 4?
The most recent primary Form 4 on record is dated 25 June 2026, one of 8 filings going back to 2025.
Has David W. J. McGirr been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($4.72M) across all tracked filings.
